Cargando…
Novel direct AMPK activator suppresses non-small cell lung cancer through inhibition of lipid metabolism
Drug resistance is becoming an obstacle in anti-cancer therapies. For target-based therapy of lung cancer, gefitinib, as the first generation of tyrosine kinase inhibitors (TKIs), demonstrated good initial response to the non-small cell lung cancer (NSCLC) patients whom harbors epidermal growth fact...
Autores principales: | Chen, Xi, Xie, Chun, Fan, Xing-Xing, Jiang, Ze-Bo, Wong, Vincent Kam-Wai, Xu, Jia-Hui, Yao, Xiao-Jun, Liu, Liang, Leung, Elaine Lai-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707083/ https://www.ncbi.nlm.nih.gov/pubmed/29221189 http://dx.doi.org/10.18632/oncotarget.21716 |
Ejemplares similares
-
Suppression of PD‐L1 release from small extracellular vesicles promotes systemic anti‐tumor immunity by targeting ORAI1 calcium channels
por: Chen, Xi, et al.
Publicado: (2022) -
Evodiamine suppresses non-small cell lung cancer by elevating CD8(+) T cells and downregulating the MUC1-C/PD-L1 axis
por: Jiang, Ze-Bo, et al.
Publicado: (2020) -
Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death
por: Law, Betty Yuen Kwan, et al.
Publicado: (2017) -
Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation
por: Li, Run-Ze, et al.
Publicado: (2018) -
(Z)3,4,5,4′-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level
por: Fan, Xing-Xing, et al.
Publicado: (2015)